Cme (CME) Free Cash Flow (2010 - 2026)

Cme (CME) has reported Free Cash Flow for 17 consecutive years, with $923.5 million the latest figure, recorded in Q2 2026.

• Quarterly Free Cash Flow fell 11.21% year-over-year to $923.5 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $4.2 billion (up 2.56% YoY) and the FY2025 annual result came in at $4.2 billion, up 16.6% from the prior year.
• Free Cash Flow slipped to $923.5 million in Q2 2026 per CME's latest filing, from $1.2 billion in the prior quarter.
• Over the last five years, Free Cash Flow for CME reached as high as $1.2 billion in Q1 2026 and fell as low as $599.7 million in Q2 2022.
• A 5-year average of $905.3 million and a median of $936.6 million in 2025 frame the typical range for Free Cash Flow.
• Annual changes were most pronounced in 2022 — Free Cash Flow soared 49.31% — and 2026, when it retreated 11.21%.
• Year by year, Free Cash Flow stood at $957.1 million in 2022, then increased by 6.94% to $1.0 billion in 2023, then fell by 3.11% to $991.7 million in 2024, then increased by 11.06% to $1.1 billion in 2025, then fell by 16.15% to $923.5 million in 2026.
• According to Business Quant data, Free Cash Flow over the past three periods registered $923.5 million, $1.2 billion, and $1.1 billion for Q2 2026, Q1 2026, and Q4 2025 respectively.